Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02998918 · ClinicalTrials.gov registry record · NA
Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02998918 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 21 participants.
The verdict
NCT02998918, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Polyphenol supplements, including curcumin and resveratrol, are known to decrease inflammation, but previous polyphenol supplements were poorly absorbed and thus their effects were reduced. A new phytosome formulation coats the supplements and allows them to be better absorbed. The purpose of this study is to examine the acute (1-hr) and short-term (1-week) effects of two different phytosome-formulated polyphenol supplements on inflammation. The two supplements that will be used are: 1) PolyResveratrol and 2) Curcumin.
Interventions
- DIETARY_SUPPLEMENT PolyResveratrol Supplementation
- DIETARY_SUPPLEMENT Curcumin Supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2016-09 |
| Est. Completion | 2020-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02998918
The ClinicalTrials.gov registry entry for NCT02998918 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PolyResveratrol Supplementation is the first listed.
NCT02998918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02998918 about?
NCT02998918 is a clinical study titled "Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL". Polyphenol supplements, including curcumin and resveratrol, are known to decrease inflammation, but previous polyphenol supplements were poorly absorbed and thus their effects were reduced. A new phytosome formulation coats the supplements and allows them to be better absorbed. The purpose of this s...
What is the current status of trial NCT02998918?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2016-09. Estimated completion is 2020-06.
What interventions are being tested in trial NCT02998918?
The interventions under investigation include: PolyResveratrol Supplementation (DIETARY_SUPPLEMENT), Curcumin Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02998918?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.